Related Experiment Video
Updated: Jul 22, 2026
10:40
Homing of Hematopoietic Cells to the Bone Marrow
Published on: March 18, 2009
[Association between malignant hematologic diseases and cancer]
1V. Belgyógyászati Osztály, Szabolcs-Szatmár-Bereg Megyei Kórház, Nyíregyháza.
Orvosi Hetilap
|November 20, 1994
Summary
This study analyzed 56 cases of secondary cancers in patients with malignant hematologic diseases. Researchers found associations between initial treatments and the development of subsequent malignancies, highlighting potential causal links.
Area of Science:
- Hematology
- Oncology
- Cancer Epidemiology
Context:
- A 10-year period (1983-1993) observed 56 cases of co-occurring cancers and hematologic malignancies.
- Analysis focused on the sequence and timing of diagnoses: initial cancer (15 cases), initial hematologic malignancy (20 cases), and simultaneous diagnoses (21 cases).
Purpose:
- To investigate the occurrence and patterns of secondary malignancies in patients with hematologic diseases.
- To explore potential causal associations between treatments for initial diseases and the development of subsequent cancers.
Summary:
- Of 56 registered cases, 45 involved a second malignancy diagnosed during the patient's lifetime.
- Most patients developed one hematologic malignancy and one cancer, with seven cases suggesting a causal link to prior treatment.
- The study identified 56 associations between malignant hematologic diseases and cancers over a decade.
Impact:
- Highlights the importance of monitoring for secondary malignancies in hematologic disease patients.
- Suggests that treatment modalities for initial hematologic conditions may influence secondary cancer risk.
- Provides epidemiological data on cancer-hematologic malignancy associations for further research.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...